⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL299670 | 1.00 | — | — | |
| SCHEMBL132799 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL14311857 | 0.98 | L3MBTL1 (0.46) | — | |
| Hydrochloric Acid SCHEMBL2673114 | 0.98 | L3MBTL1 (0.46) | — | |
| Hydrochloric Acid SCHEMBL14888081 | 0.98 | L3MBTL1 (0.46) | — | |
| SCHEMBL4368176 | 0.93 | L3MBTL1 (0.42) | — | |
| Bromide SCHEMBL10745331 | 0.91 | L3MBTL1 (0.41) | — | |
| SCHEMBL4374453 | 0.91 | L3MBTL1 (0.41) | — | |
| Hydrochloric Acid SCHEMBL9582171 | 0.91 | L3MBTL1 (0.41) | — | |
| SCHEMBL10867057 | 0.89 | L3MBTL1 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 344 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240279171-A1 | METHODS FOR PREPARING CRYSTALLINE FORMS OF AMISULPRIDE | SUNOVION PHARMACEUTICALS INC (US) | 2024-08-22 | — | — | US | claimed |
| CN-116925152-A | Amino phenol iron complex and preparation method and application thereof | 中国石油大学(北京) | 2023-10-24 | — | — | CN | claimed |
| WO-2022256482-A1 | METHODS FOR PREPARING CRYSTALLINE FORMS OF AMISULPRIDE | SUNOVION PHARMACEUTICALS INC. (US) | 2022-12-08 | — | — | WO | claimed |
| CN-111153845-A | Preparation method of(s) -N-ethyl-2-aminomethyl pyrrolidine | 北京万全德众医药生物技术有限公司 | 2020-05-15 | — | — | CN | claimed |
| EP-2576537-B1 | 2-AMINO-PYRIMIDINE DERIVATIVES USEFUL AS INHIBITORS OF JNK | HOFFMANN LA ROCHE (CH) | 2016-03-16 | — | — | EP | claimed |
| CN-104190466-A | Multiphase asymmetric cascade reaction catalyst with synergistic effect of acid site and base site and preparation method of multiphase asymmetric cascade reaction catalyst | UNIV BEIJING CHEMICAL | 2014-12-10 | — | — | CN | claimed |
| US-8642601-B2 | Inhibitors of JNK | ROCHE PALO ALTO LLC (US) | 2014-02-04 | — | — | US | claimed |
| US-20110301171-A1 | Inhibitors of JNK | ARZENO HUMBERTO BARTOLOME (US) | 2011-12-08 | — | — | US | claimed |
| EP-1469005-B1 | Process for the asymmetric hydrogenation of ketocarbonic acid esters | SALTIGO GMBH (DE) | 2006-08-30 | — | — | EP | claimed |
| EP-1567507-B1 | 1,2,3- TRIAZOLE AMIDE DERIVATIVES AS CYTOKINE INHIBITORS | BOEHRINGER INGELHEIM PHARMA (US) | 2006-06-14 | — | — | EP | claimed |
| US-20040102492-A1 | Cytokine inhibitors | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. | 2004-05-27 | — | — | US | claimed |
| US-12503451-B2 | 2-arylthiazole derivative or salt thereof, preparation method therefor, and pharmaceutical composition comprising same | HEXAPHARMATEC CO., LTD. (KR) | 2025-12-23 | — | — | US | disclosed |
| US-20250161307-A1 | PYRAZOLOPYRIMIDINES AS MODULATORS OF SPERMINE OXIDASE | JANSSEN PHARMACEUTICA NV (BE) | 2025-05-22 | — | — | US | disclosed |
| CN-119985746-A | Method for detecting impurity A in amisulpride oral liquid and application thereof | 江苏长泰药业股份有限公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-119020865-B | Chiral halide perovskite single crystal and preparation method and application thereof | 暨南大学 | 2025-05-06 | — | — | CN | disclosed |
| WO-1987007271-A1 | A STEREOCONSERVATIVE SYNTHESIS OF 1-SUBSTITUTED (S)- AND (R)-2-AMINOMETHYLPYRROLIDINES AND INTERMEDIATES THERETO | Astra Läkemedel Aktiebolag (SE) | 1987-12-03 | — | — | WO | disclosed |
| US-4695574-A | HYPOTENSIVE AGENTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1987-09-22 | — | — | US | disclosed |
| EP-0207913-A1 | Catechol carboxamides, process for their preparation, intermediates and a pharmaceutical preparation | Astra Läkemedel Aktiebolag (SE) | 1987-01-07 | — | — | EP | disclosed |
| WO-1986007591-A1 | CATECHOLCARBOXAMIDES, PROCESS FOR THEIR PREPARATION, INTERMEDIATES AND A PHARMACEUTICAL PREPARATION | Astra Läkemedel Aktiebolag (SE) | 1986-12-31 | — | — | WO | disclosed |
| EP-0156776-A1 | Derivatives of N-(2-pyrrolidinylmethyl)-benzamide, process for their preparation, intermediates and a pharmaceutical preparation | Astra Läkemedel Aktiebolag (SE) | 1985-10-02 | — | — | EP | disclosed |